Mitchell Rosenberg
Impact in
- Physiology top 5%
- Asthma and respiratory diseases
- Immunology and Allergy top 5%
- Allergic Rhinitis and Sensitization
Papers in
-
- Drug-Induced Adverse Reactions 2
- Cholinesterase and Neurodegenerative Diseases 1
- Oncology 4
- Peptidase Inhibition and Analysis 2
- Co-authors
- Elliot Israel (5 shared papers)Jeffrey M. Drazen (4 shared papers)Paul Rubin (3 shared papers)Andrew R. Fischer (3 shared papers)Craig M. Lilly (2 shared papers)J. Cohn (2 shared papers)Graham W. Taylor (1 shared paper)Richard I. Sperling (1 shared paper)
- Journals
- JNCI Monographs (2 papers)Experimental Cell Research (2 papers)The Journal of Clinical Pharmacology (2 papers)Journal of Allergy and Clinical Immunology (2 papers)British Journal of Clinical Pharmacology (1 paper)
- Partner nations
- United StatesSwitzerlandFrance
In The Last Decade
Mitchell Rosenberg
17 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 100
- Physiology 605
- Immunology and Allergy 138
- Pharmacology 256
- Pulmonary and Respiratory Medicine 361
- Emergency Medical Services 53
Countries citing papers authored by Mitchell Rosenberg
This map shows the geographic impact of Mitchell Rosenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell Rosenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell Rosenberg more than expected).
Fields of papers citing papers by Mitchell Rosenberg
This network shows the impact of papers produced by Mitchell Rosenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell Rosenberg. The network helps show where Mitchell Rosenberg may publish in the future.
Co-authors
The 25 scholars most cited alongside Mitchell Rosenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1990 | 328 | |
| 2 | 1993 | 313 | |
| 3 | 1994 | 146 | |
| 4 | 2006 | 129 | |
| 5 | 1997 | 109 | |
| 6 | 2006 | 93 | |
| 7 | 2007 | 58 | |
| 8 | 2007 | 52 | |
| 9 | 2006 | 45 | |
| 10 | 1992 | 40 | |
| 11 | 2007 | 39 | |
| 12 | 2007 | 33 | |
| 13 | 1997 | 20 | |
| 14 | 2009 | 13 | |
| 15 | 1969 | 8 | |
| 16 | 2021 | 5 | |
| 17 | 2000 | 2 |
About Mitchell Rosenberg
Mitchell Rosenberg is a scholar working on Pharmacology, Oncology, Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Physiology, having authored 17 papers that have together received 1.4k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (3 papers), Asthma and respiratory diseases (3 papers), Drug-Induced Adverse Reactions (2 papers), Peptidase Inhibition and Analysis (2 papers), Cancer Genomics and Diagnostics (1 paper), Polymer Surface Interaction Studies (1 paper), Antifungal resistance and susceptibility (1 paper) and Cholinesterase and Neurodegenerative Diseases (1 paper). The work is most often cited by research in Physiology (605 citations), Immunology and Allergy (138 citations), Pharmacology (256 citations), Pulmonary and Respiratory Medicine (361 citations) and Emergency Medical Services (53 citations). Mitchell Rosenberg has collaborated with scholars based in United States, Switzerland and France. Frequent co-authors include Elliot Israel, Jeffrey M. Drazen, Paul Rubin, Andrew R. Fischer, Craig M. Lilly, J. Cohn, Graham W. Taylor, Richard I. Sperling, Jerry Shapiro and Patrick Remington. Their work appears in journals such as JNCI Monographs, Experimental Cell Research, The Journal of Clinical Pharmacology, Journal of Allergy and Clinical Immunology and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.